Talking about what others are afraid to say
Patients aren’t just searching for health information anymore. They’re demanding answers. That reality should alarm every pharma executive who oversees medical affairs, patient safety, regulatory affairs, corporate communications, digital strategy, …
Pharma Is Losing Control of the Medical Answer Read More
Antidepressant prescriptions have skyrocketed over the past few decades, prompting a vital question: Are these medications being overprescribed? To answer this, let’s look at the data—and interpret it in context.
Are Antidepressants Being Prescribed Too Much? A Data-Driven Look Read More
The new food pyramid repeats the core flaw of the old one: it prioritizes political and institutional comfort over metabolic and clinical reality. While the language has evolved, the guidance …
The New Food Pyramid Is Bad Advice. Can We Ever Trust the Government Again on Health? Read More
In 2026, healthcare isn’t a niche policy issue — it’s a cultural, political, and personal one. That puts pharma DTC in a very different position than it was even a …
In 2026, With Healthcare in the Spotlight, Pharma DTC Needs to Change Read More
Biomarkers are at the heart of modern cancer treatment, yet patients rarely hear about them from drug companies. For pharma, these tests complicate the marketing pitch—they signal a drug isn’t …
Should Pharma Companies Explain the Value of Biomarkers When Discussing Cancer Treatment Options? Read More
Most pharma direct-to-consumer (DTC) marketers still operate under outdated assumptions about how patients make treatment decisions. They often rely on broad awareness tactics and brand recall, assuming that exposure leads …
Do Pharma DTC Marketers Understand How Patients Make Treatment Choices? Read More
A new study published this week in JAMA is forcing a tough conversation about the latest wave of weight-loss drugs: what happens when you stop taking them? The research looked …
Long-Term Use of Tirzepatide Might Be Necessary Read More
Gallup’s latest data tells a sobering story: 9.7% of U.S. adults now report having been diagnosed with cancer—a sharp rise from 7.0% in 2008–2009. For years, that figure held steady at just …
Rising Cancer Rates: Understanding the 9.7% Diagnosis in the U.S. Read More